Sort
21,281 grants matching “influenza”
Comparative Genomics: Mechanism(s) Against Emerging Infectious Diseases
$1,297,476Stephen J O'Brien · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Task V03: Product Development Plans
$1,297,428Thomas Hassell · International Aids Vaccine Initiative · N01 · FY2019 · AI
Antigen Processing And Presentation In The Intestine
$1,297,248Brian Kelsall · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
The effects of immune-age on immune-response and the molecular mechanisms which drive it
$1,296,948Shai Shlomo Shen-Orr · Stanford University · P01 · FY2023 · AI
Influenza Viral Pathogenesis
$1,296,634Jeffery Taubenberger · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)
$1,296,120Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · N01 · FY2019 · AI
Innate inflammatory responses during pulmonary infections
$1,293,685Katrin Mayer-Barber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
THE FLORIDA DEPT OF HLTH INFLUENZA ELECTRONIC DATA EXCHANGE INTEROPERABILITY
$1,292,798Rhonda White · Florida State Department Of Health · U90 · FY2008 · TP
Clinical Trials of Vaccines for Respiratory Syncytial Virus and Related Viruses
$1,290,899Ursula Buchholz · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Human Respiratory Syncytial Virus Biology And Vaccine Development
$1,290,643Peter Leon Collins · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Evaluating Modes of Influenza Transmission using a Randomized Controlled Trial (EMIT-2-RCT)
$1,289,028Donald K Milton · Univ Of Maryland, College Park · U19 · FY2023 · AI
Regulation of MHC Class II Trafficking in Antigen Presenting Cells
$1,288,069Paul Roche · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Emerging respiratory viruses - pathogenesis and countermeasures
$1,286,793Emmie De Wit · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Center for Computational Mass-Spectrometry
$1,285,619Pavel A Pevzner · University Of California, San Diego · P41 · FY2009 · RR
Origin and maturation of protective memory B cell responses against pathogenic viruses in natural infections and upon vaccination.
$1,285,073Mattia Bonsignori · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Cincinnati Children's Hospital Medical Center Vaccine and Treatment Evaluation Units (UM1 Clinical Trial Required)-DMID 21-0012
$1,283,750Robert Wilson Frenck · Cincinnati Childrens Hosp Med Ctr · UM1 · FY2021 · AI
Vaccine and Treatment Evaluation Units
$1,282,926Nadine Georges Rouphael · Emory University · UM1 · FY2025 · AI
Vaccine Induced Immunity in the Young and Aged
$1,280,745Rafi Ahmed · Emory University · U19 · FY2009 · AI
Experimental characterization of the dynamics of immune responses to influenza
$1,280,261Rafi Ahmed · Emory University · U19 · FY2018 · AI
Advanced Development of Vaccines for Influenza
$1,280,042Uwe Staerz · Greffex, Inc. · N01 · FY2022 · AI
Mass Spectrometry Resource for Biology and Medicine
$1,278,355Catherine E. Costello · Boston University Medical Campus · P41 · FY2017 · GM
Virus-Like Particle Vaccines for Pandemic Influenza
$1,278,207Ted M Ross · University Of Pittsburgh At Pittsburgh · U01 · FY2009 · AI
Clinical Trial of Oseltamivir Efficacy for Reducing Influenza Severity
$1,277,517Edward Belongia · Marshfield Clinic Research Foundation · U01 · FY2007 · IP
Vaccine immunogenicity and efficacy in the rhesus macaque/SHIV model
$1,277,195Ruth Margrit Ruprecht · University Of Louisiana At Lafayette · U19 · FY2023 · AI
Systems Biology Analysis of Influenza A Virus and Ebola Virus
$1,276,716Yoshihiro Kawaoka · University Of Wisconsin-Madison · U19 · FY2014 · AI